Context: Uterine fibroids (UFs) are the most common benign tumors in premenopausal women. In this study, we evaluated the effects of 1,25-dihydroxyvitamin D3 [1, 25(OH) 2 D3] for the treatment of UFs.
U
terine fibroids (UFs; or leiomyomas) are the leading cause of hysterectomy in women of reproductive age (1) (2) (3) . Increasing evidence supports the theory that ovarian steroids such as estrogen and progesterone play key roles in the growth of UFs (4 -6) . UFs are three to four times more likely to occur in African American women, who also suffer from vitamin D deficiency, compared to their Caucasian counterparts (7, 8) . The exact cause of this markedly high occurrence of UFs is not yet fully understood, but such association may suggest a role for vitamin D in fibroid biology. We and others have recently reported that women with UFs have lower levels of serum vitamin D3 compared to women who do not have UFs (9 -11) . Moreover, we also demonstrated a direct association of lower levels of serum vitamin D3 with increased size of UFs within different ethnic groups (9) . 1,25-Dihydroxyvitamin D3 [1, 25(OH) 2 D3] is a member of the steroid hormone family and serves as the major regulator of calcium and phosphate homeostasis in the body system (12) . Studies have shown that 1,25(OH) 2 D3 can induce growth arrest, differentiation, and apoptosis in a wide variety of cancer cells (13, 14) . Recent studies have demonstrated that 1,25(OH) 2 D3 or its noncalcemic analog, paricalcitol, inhibits fibroid tumor growth in vivo and can inhibit proliferation of human UF cells in vitro (15) (16) (17) . Furthermore, we also demonstrated that 1,25(OH) 2 D3 can inhibit the expression and activities of matrix metalloproteinases and reduce the expression of extracellular matrix proteins in cultured UF cells (18, 19) .
In a 2004 report of Andersen et al (20) , it is clearly illustrated that fibroid primary cultures have an elevated response to 17␤-estradiol compared with myometrial cultures. UFs are responsive to sex steroid hormones, and such responsiveness is enhanced in rodent and human tumors as well as tumor-derived cell lines as compared to their myometrial counterparts (2, 21, 22) . The effects of estrogen are mediated primarily via estrogen receptor (ER)-␣, the nuclear receptor that belongs to a superfamily of ligand-regulated transcription factors (23) . Subsequent to estradiol binding to ER-␣, the receptor undergoes a conformational change, dimerizes, and binds either directly to DNA via estrogen response elements or indirectly via interactions with other DNA-bound transcription factors such as Sp1 or AP-1 (23) (24) (25) . Estrogen exerts its biological effect in estrogen-responsive tissues by binding to ER-␣ and modulating the transcription of target genes including growth factors and proto-oncogenes, among others (26) . Moreover, nongenomic effects of estrogen can be induced by cytoplasmic signaling pathways, which include the activation of the MAPK pathway transduced from growth factor receptors or plasma membrane localized ER (27, 28) . Because estrogen functions via binding with ER-␣ (29), the factors and mechanisms that regulate the level of ER-␣ are important in determining the amplitude of estrogen-mediated actions in UFs. This knowledge will augment our efforts in the development of new therapeutic approaches for the treatment of UFs.
Recent studies demonstrated that 1,25(OH) 2 D3 can reduce gene expression of ER-␣ in human breast cancer cells (30) . We have recently reported that lower levels of vitamin D receptor (VDR) are associated with a higher risk of UF pathogenesis (19) . Published literature also demonstrates up-regulation of steroid receptors, particularly ER-␣ in UFs as compared with the adjacent myometrium, yet nothing is known as to whether there is an association between the expression status of these sex steroid receptors and lower levels of VDR. It has also not been determined whether 1,25(OH) 2 D3 plays an important role in the regulation of sex steroid hormone receptors in UF cells. The aim of this study is to evaluate whether a possible correlation exists between the higher expression of steroid receptors and lower levels of VDR in human UF and to determine whether 1,25(OH) 2 D3 has the potential to suppress the expression of those receptors in cultured human UF cells, thus implicating a potential nonsurgical therapeutic utility for the treatment of UFs.
Materials and Methods

Cell lines and cultures
Human uterine leiomyoma (HuLM) cells were a kind gift from Dr Darlene Dixon (National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina) (31) . These cells were grown in smooth muscle basal medium at 37°C in a humidified atmosphere of 5% CO 2 as previously described (32) . Primary human UF cells used in this study were described in our prior publications (18) .
Reagents and antibodies
1,25(OH) 2 D3, estrogen, protein G-sepharose, fluorescein isothiocyanate (FITC)-conjugated phalloidin, and anti-␤-actin antibodies were purchased from Sigma Biochemicals. NE-PER nuclear and cytoplasmic extraction reagents were purchased from Pierce Biotechnology. Anti-ER-␣, anti-PR-A, anti-PR-B, anti-VDR, anti-retinoid X receptor (RXR)-␣, anti-poly (ADPribose) polymerase (PARP), and anti-rho GDP-dissociation inhibitor (RhoGDI) antibodies were purchased from Santa Cruz Biotechnology. CY3-and FITC-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc. Anti-SRC1, anti-SRC2, and anti-SRC3 antibodies were purchased from Thermo Scientific.
Protein extraction from human tissue samples
Human UFs and the adjacent myometrium tissue samples were collected from consenting individuals undergoing surgery (hysterectomy or myomectomy) for UF removal (abdominal, vaginal, and laparoscopic). Tissue samples were collected at various locations within Texas and Tennessee under approved Institutional Review Board protocols (Protocol no. 090630WJR246 11). Methodology for the extraction of proteins from stored tissue samples has been previously described (19) . Using Western blot analyses, protein lysates were examined for the expression of ER-␣, PR-A, PR-B, VDR, and members of the steroid receptor coactivator (SRC) family.
Cell proliferation assay
Cell counts were conducted to determine the effect of 1,25(OH) 2 D3 on estrogen-induced proliferation of HuLM cells. HuLM cells were seeded onto 12-well tissue culture plates (Becton Dickinson) and treated with estrogen in the absence or presence of increasing doses of 1,25(OH) 2 D3 at different time points; then cells were counted at each time point as described in the figure legend (see Figure 2A) . Averaged cell numbers from triplicate wells were used in preparing the graph. Each data point represents the mean Ϯ SD of triplicate wells (n ϭ 3). 
Coimmunoprecipitation (Co-IP) analyses
To determine the physical interaction between VDR and RXR-␣ in HuLM cells, we performed a Co-IP assay as previously described (15) . We seeded 2 ϫ 10 6 HuLM cells in 10-cm tissue culture dishes and incubated them overnight. Cells were preincubated in serum-free medium for 20 hours and treated with increasing doses of 1,25(OH) 2 D3 for 48 hours; cell lysates were prepared as previously described (15) . For Co-IP assay, equal amounts (1 mg) of clear lysates were incubated with 2.5 g polyclonal anti-RXR-␣ antibody for 2.5 hours at 4°C, followed by incubation with 25 L of protein G-Sepharose for an additional hour. Immunoprecipitates were assayed by Western blot analyses using polyclonal anti-VDR antibody. Similarly, Co-IP was performed with anti-VDR antibody, and then Western blot analyses were performed with anti-RXR-␣ antibody. Western blot analyses were also performed to verify expression of VDR and RXR-␣ in the above lysates.
Nuclear and cytoplasmic fractions
HuLM cells (2 ϫ 10 6 ) were seeded in 10-cm tissue culture dishes and incubated overnight. Cells were preincubated in serum-free medium for 20 hours and treated with increasing doses of 1,25(OH) 2 D3 for 48 hours. Thereafter, nuclear and cytoplasmic fractions were prepared from pelleted cells using NE-PER nuclear and cytoplasmic extraction reagents; 15 g of each cytoplasmic and nuclear fraction was subjected to Western blot analyses using antibodies as indicated in figure legends (see Figures 3D and 5D ).
Immunofluorescence analyses
Immunofluorescence analyses were conducted as previously described (15) . Briefly, HuLM cells were cultured, serum starved, and subsequently treated with 1,25(OH) 2 D3 for 48 hours. After fixation/permeabilization steps, cells were incubated with either mouse monoclonal or rabbit polyclonal primary antibodies for 1 hour at room temperature, followed by an additional 1-hour incubation with CY3-or FITC-conjugated mouse monoclonal or rabbit polyclonal secondary antibodies. Fluorescent images were taken using an Axiovert 100 M inverted microscope (Nikon TE2000-E fluorescence microscope). Signal intensities were visually compared between untreated control and 1,25(OH) 2 D3-treated cells.
Statistical analysis
Student's t test was used in assessing significant differences in the expression levels of ER-␣, PR-A, and PR-B in human UF vs adjacent myometrium samples. Student's t test was also used to assess any significant differences between untreated control vs 1,25(OH) 2 D3-treated data points and within the 1,25(OH) 2 D3-treated data points. Values were considered statistically significant at a 95% confidence level when P Ͻ .05. Data were presented as the mean Ϯ SD.
Results
Up-regulation of ER-␣ and PRs correlated with reduced levels of VDR in human UF tumors
To determine whether up-regulation of sex steroid receptors correlates with lower levels of VDR in human UFs, we performed Western blot analyses using protein lysates prepared from several independent human UF lesions and adjacent myometrium. Our results demonstrated that at least 70% of UF lesions (10 of 14 patients) expressed an induced level of ER-␣. Similarly, expression levels of PR-A and PR-B were also up-regulated in UFs ( Figure 1A ). We observed that VDR expression was lower in 60% of cases (eight of 14) in UFs compared to adjacent myometrium. Correlation between up-regulation of ER-␣ and reduced expression of VDR was observed in five of 10 cases of UF ( Figure 1A ). To further verify whether human UF expressed deregulated CYP27B1 (an enzyme responsible for synthesizing the active form of vitamin D3), we applied immunohistochemical analyses. We found lower levels of both CYP27B1 and VDR in UF when compared with the adjacent myometrium ( Figure 1B ), suggesting that both vitamin D synthesis and signaling apparatus are diminished in UF. Thus, the above results suggest an inverse correlation between higher levels of ER-␣, PR-A, and PR-B and lower levels of VDR in human UF.
1,25(OH) 2 D3 inhibits estrogen-induced proliferation of cultured HuLM cells
To determine whether estrogen can induce proliferation of HuLM cells, whereas treatment with 1,25(OH) 2 D3 suppresses estrogen-induced proliferation, we performed a cell proliferation assay. We found that estrogen at 10 nM concentration slightly induced HuLM cell proliferation at 48 hours and that induction was further enhanced in a timedependent manner. Estrogen significantly induced the proliferation of HuLM cells at 96 hours (1.3-fold; P Ͻ .05) and 144 hours (1.5-fold; P Ͻ .05) (Figure 2A ). On the other hand, 1,25(OH) 2 D3 significantly inhibited estrogen-induced proliferation of HuLM cells in a dose-dependent manner ( Figure  2A ; P Ͻ .05). To examine whether estrogen induces HuLM cell proliferation by affecting the expression of VDR, we performed Western blot analyses ( Figure 2B ). We found that estrogen reduced the expression of VDR in a dose-dependent manner in HuLM cells ( Figure 2B ). We further observed that estrogen or progesterone treatment affects the expression of steroid receptors by performing Western blot analyses. We found that either estrogen or progesterone significantly in-duced the levels of PR-A and PR-B in HuLM cells, whereas the levels of ER-␣ did not show significant changes (Figure 2 , C and D). Additionally, the levels of SRC1, SRC2, and SRC3 were not affected by estrogen or progesterone ( Figure 2C ). These results suggest that estrogen induces growth of HuLM cells, whereas 1,25(OH) 2 D3 function by inhibiting the growth-promoting effects of estrogen on cultured HuLM cells.
1,25(OH) 2 D3 treatment reduces the expression of ER-␣, PR-A, and PR-B proteins in cultured HuLM cells
To examine whether 1,25(OH) 2 D3 reduces the expression of sex steroid hormone receptors, we performed Western blot analyses. We found that 1,25(OH) 2 D3 reduced the levels of ER-␣ in a dose-and time-dependent manner when compared with untreated controls ( Figure  3A ). 1,25(OH) 2 D3 at 10 nM concentration significantly reduced the levels of ER-␣ protein, which was further reduced by higher concentrations of 1,25(OH) 2 D3 ( Figure  3A ). On the other hand, 1,25(OH) 2 D3 induced the levels of VDR in a dose-and time-dependent manner in HuLM cells. In parallel, we also found that 1,25(OH) 2 D3 at 10 nM concentration significantly reduced levels of PR-A and PR-B in HuLM cells, which was also further reduced by higher concentrations ( Figure 3B ). Using immunofluorescence analyses, we further observed that HuLM cells showed clear structural smooth muscle F-actin staining, whereas 1,25(OH) 2 D3 reduced staining in a dose-dependent manner (Supplemental Figure 1) . Using immunofluorescence analyses, we found that ER-␣, PR-A, and PR-B staining signals (red) were primarily localized in the nuclei of HuLM cells ( Figure  3C ). Treatment of 1,25(OH) 2 D3 at 10 nM concentration notably reduced nuclear staining, which was further reduced by higher concentrations (Figure 3C) . On the other hand, the staining signals for VDR (green) were also present in the nuclei of HuLM cells, whereas 1,25(OH) 2 D3 induced nuclear VDR staining in a dose-dependent manner ( Figure 3C , top panel). With Western blot analyses using cytoplasmic and nuclear fractions, we further confirmed the presence of ER-␣, PR-A, and PR-B in the nuclear fractions, whereas 1,25(OH) 2 D3 decreased those nuclear receptors in a dose-dependent manner ( Figure 3D ). On the other hand, 1,25(OH) 2 D3 induced the levels of VDR in nuclear fractions in a dose-dependent manner in HuLM cells ( Figure 3D ). To further mimic these findings in human UFs, we performed similar immunofluorescence and Western blot analyses and showed that 1,25(OH) 2 D3 induced nuclear VDR and reduced nuclear ER-␣ in primary fibroid cells (Supplemental Figure  2) . These results suggest that 1,25(OH) 2 D3 reduces the expression of nuclear ER-␣, PR-A, and PR-B in cultured HuLM cells.
Human UFs express higher levels of sex SRC family proteins, SRC2 and SRC3, when compared with adjacent myometrium
To test whether SRCs are up-regulated in human UFs, we performed Western blot analyses using protein samples isolated from human UFs and their adjacent myometrium. We found that SRC2 was overexpressed in 50% of the cases (seven of 14) of UFs, whereas the SRC3 was overexpressed in 40% of cases (six of 14) as compared with adjacent myometrium (Figure 4) . These results indicate that human UFs express higher levels of SRC2 and SRC3 proteins and that up-regulation may have an impact in the tumorigenicity of UFs. on expression and subcellular localization of SRCs in HuLM cells, we performed immunofluorescence analyses. We found that staining signals for both SRC2 and SRC3 (red) were mainly localized in the nuclei of HuLM cells, whereas 1,25(OH) 2 D3 reduced those staining signals in a dose-dependent manner ( Figure 5C , middle and bottom panels). In contrast, staining signals for SRC1 (red) were somewhat localized in both chambers with more intensity in the nuclei and wherein signals were also reduced by 1,25(OH) 2 D3 in a dose-dependent manner ( Figure 5C , Figure 2 . Effect of 1,25(OH) 2 D3 on estrogen-induced proliferation of cultured human UF cells. A, HuLM cells (5000 cells/well) in 12-well plates were cultured in phenol free smooth muscle basal medium containing 5% fetal bovine serum. Cells were treated with 10 nM estrogen with or without varying doses of 1,25(OH) 2 D3 (100 and 1000 nM) for 48, 96, and 144 hours. Cultures were replenished every other day with fresh conditioned media. Cells were trypsinized at each time point and counted using cell-counting chamber slides. Each data point is the mean Ϯ SD of triplicate wells (n ϭ 3). *, P Ͻ .05 as compared to the corresponding control. **, P Ͻ .05 as compared to treatment points. B, Estrogen treatment reduced the levels of VDR in HuLM cells. HuLM cells (0.7 ϫ 10 6 ) were cultured in 60-mm dishes, serum starved in phenol free DMEM/F12 medium, and treated with increasing doses of estrogen for 48 hours, as indicated. Equal amounts of each cell lysate were analyzed by Western blot using polyclonal anti-VDR antibody. Western blot with anti-␤-actin antibody was used as the loading control. The intensity of each protein band was quantified and normalized to ␤-actin, and relative values were used to generate graphic data. *, P Ͻ .05 compared to corresponding control. **, P Ͻ .05 indicates the significance between consecutive doses. C, Estrogen or progesterone treatment induced PRs in HuLM cells. HuLM cells were cultured and serum starved as described above. Cells were treated with different doses of estrogen or progesterone or in combination (estrogen and progesterone together) for 48 hours as indicated. Cell lysates were analyzed by Western blot using anti-ER-␣, anti-PR-A, anti-PR-B, anti-SRC1, anti-SRC2, and anti-SRC3 antibodies. Western blot with anti-␤-actin antibody was used as the loading control. D, The intensities of above ER-␣, PR-A, and PR-B protein bands were quantified and normalized to ␤-actin, and relative values were used to generate graphic data. *, P Ͻ .05 as compared to the corresponding control.
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Al-Hendy et al Effect of 1,25(OH) 2 D3 on Sex Steroid Receptors J Clin Endocrinol Metab, April 2015, 100(4):E572-E582 top panel). We further quantitatively determined the effects of 1,25(OH) 2 D3 on nuclear SRC2 and SRC3 by performing Western blot analysis using cytoplasmic and nuclear fractions, as described in Figure 3D . We found that both SRC2 and SRC3 were present in the nuclei of HuLM cells, whereas 1,25(OH) 2 D3 reduced the levels of those proteins in a dose-dependent manner ( Figure 5D ). As expected, we noticed that 1,25(OH) 2 D3 consistently induced the levels of VDR in a dose-dependent manner in HuLM cells ( Figure 5D ). To further mimic these findings ) were subjected to Western blot analyses using anti-ER-␣, anti-PR-A, anti-PR-B, and anti-VDR antibodies. Western blot with anti-PARP (a nuclear protein) and anti-RhoGDI (a cytoplasmic protein) antibodies were used to ensure the extraction efficiency. The expression of PARP was almost exclusively localized in the nuclear fractions, whereas the expression of RhoGDI was almost exclusively localized in the cytosolic fractions. NS, nonspecific. Figure 2 ). These results suggest that 1,25(OH) 2 D3 reduces the expression levels of nuclear SRC family members in cultured human HuLM cells.
1,25(OH) 2 D3 treatment induces physical association between VDR and RXR-␣ in cultured HuLM cells
To determine whether VDR and RXR-␣ interact to form VDR-RXR-␣ complex in HuLM cells, we performed a Co-IP assay. Using anti-RXR-␣ antibody for Co-IP, the presence of VDR in the complex was verified by Western blot with anti-VDR antibody. We found that VDR was present in the complex, whereas 1,25(OH) 2 D3 induced that interaction as determined by the increased level of VDR in the complex ( Figure 6A, top panel) . Alternatively, using anti-VDR antibody for Co-IP, the presence of RXR-␣ protein in the complex was verified by Western blot with anti-RXR-␣ antibody. Unlike the VDR findings above, we found that similar levels of RXR-␣ were present in the complex, and such levels were not altered by 1,25(OH) 2 D3 ( Figure 6A, bottom panel) . Consistent with Western blot data, our immunofluorescence analyses also confirmed that 1,25(OH) 2 D3 induced the expression levels of VDR (green, top panel) in HuLM cells, whereas the expression levels of nuclear RXR-␣ (red, bottom panel) were unaffected by 1,25(OH) 2 D3 ( Figure 6C ). These results suggest that VDR and RXR-␣ physically interact to form the VDR-RXR-␣ complex, which is further induced by 1,25(OH) 2 D3 treatment in HuLM cells.
Discussion
The dysregulation of steroid hormones and their receptors is thought to be a primary factor for UF growth (33) . Although few reports have shown minimum differences in ER and PR mRNA levels between UFs, the vast majority of previous articles have demonstrated an increased level of ER-␣ and PR-A/B in fibroid lesions as compared to adjacent myometrium (34 -37) . These discordant data may reflect intrinsic tumor-to-tumor variations that are unavoidable and, indeed, expected in such a common disease and may reflect some anthropometric factors (weight, race, age, etc), environmental influences (diet, exposure, etc), or genetics, eg, mutation status of MED12, HMGA2, epigenetic, or other factors yet to be discovered (38 -40) . Our group, along with several others, has previously shown that both 25-hydroxyvitamin D3 deficiency and 1,25(OH) 2 D3 deficiency are risk factors for the occurrence of UFs (9 -11). We have also demonstrated that fibroid tumors express reduced levels of VDR as compared with the adjacent myometrium (19) . These findings suggest that both 1,25(OH) 2 D3 deficiency and reduced expression of VDR, and therefore cumulative attenuation of vitamin D signaling, may be contributing factors in UF pathogenesis.
To date, no study has examined the correlation of ER-␣, PR-A, and PR-B with VDR in human UFs. Moreover, the effects of 1,25(OH) 2 D3 on these nuclear receptors in human UF cells has not yet been determined. Herein, we showed higher levels of ER-␣ in 70% of cases of UFs as compared with adjacent myometrium (Figure 1) . We also observed that these specific fibroid tumors expressed higher levels of ER-␣, PR-A, and PR-B; and concurrently expressed reduced levels of VDR. Published studies have demonstrated the up-regulation of progesterone receptors (PR-A and PR-B) in UF as compared to adjacent myometrium (41, 42) . Consistent with previous findings, we also observed up-regulation of PR-A and PR-B in UF as compared to adjacent myometrium, and this up-regulation was associated with reduced levels of VDR as shown in Figure 1 . A recent study has demonstrated that deregulation of VDR and CYP27B1 occurs during breast cancer development and contributes to abrogation of tumor suppressive effects triggered by vitamin D3 (43). Our results in Figure 1B , show reduced levels of CYP27B1 and Figure 4 . Human UF expressed higher levels of SRCs as compared with the adjacent myometrium. Protein lysates were prepared from human UF or leiomyoma (L; n ϭ 14) and adjacent myometrium (M). Equal amounts of each protein lysate were assayed for the expression of SRC2 and SRC3 using Western blot analyses (top panel). The intensity of each protein band was quantified and normalized to ␤-actin, and then relative values were used to generate graphic data (bottom panels). Underlining indicates UF showing up-regulation of SRC2 and SRC3 as compared to adjacent myometrium.
VDR in UF and further confirm earlier VDR findings by Western blot analyses, suggesting overall cumulative attenuated vitamin D signaling in fibroid tumor lesions. Therefore, it is possible that higher estrogenic function may suppress 1,25(OH) 2 D3 function by both reducing the synthesis of bioactive vitamin D3 and limiting available VDR in UF cells.
A number of studies have shown that estrogen is a major player in the growth of UFs. We first confirmed that estrogen induces the proliferation of HuLM cells in a dose-and time-dependent manner (Figure 2A) . Interestingly, we found that 1,25(OH) 2 D3 effectively suppressed estrogen-induced proliferation of HuLM cells ( Figure  2A ). We also observed that estrogen inhibits VDR, whereas it induced the expression of PRs in HuLM cells (Figure 2B, C, and D) . Importantly, these results demonstrate that estrogen induces the proliferation of HuLM cells by inducing PRs and by inhibiting VDR, whereas 1,25(OH) 2 D3 functions as an antiestrogenic agent in these cells.
We further examined the effect of 1,25(OH) 2 D3 on the expression of ER-␣, PR-A, and PR-B in HuLM cells. Our results demonstrate that 1,25(OH) 2 D3 has the potential to suppress the expression of ER-␣ in HuLM cells ( Figure 3A) . In contrast, we observed that 1,25(OH) 2 D3 induced the expression of its own VDR in a dose-and time-dependent manner in these cells. Interestingly, we also observed that 1,25(OH) 2 D3 significantly reduced the expression of PR-A and PR-B in HuLM cells (Figure 3, B-D) . These findings further demonstrate that 1,25(OH) 2 D3 has the potential to suppress nuclear ER-␣, PR-A, and PR-B by inducing the nuclear VDR, which seems to function as an antiestrogen in human UF cells. Previous studies demonstrated that 1,25(OH) 2 D3 is capable of transcriptionally repressing ER-␣ gene expression, leading to a decreased estrogenic response and reduction of the proliferative stimulus for human breast tumor (44, 45) . (0, 1, 10, 100, and 1000 nM) for 48 hours, as described above. Protein lysates prepared from these treated cells were analyzed by Western blot using anti-SRC1, anti-SRC2, anti-SRC3, and anti-RXR-␣ antibodies. Western blot with anti-␤-actin antibody was used as the loading control. B, The intensities of the above SRC1, SRC2, and SRC3 protein bands were quantified and normalized to ␤-actin, and relative values were used to generate graphic data. *, P Ͻ .05, compared to corresponding control. **, P Ͻ .05 indicates significance between consecutive doses. C, Immunofluorescence analyses. HuLM cells were cultured on glass cover slips, serum starved for 20 hours, and subsequently treated with increasing doses of 1,25(OH) 2 D3 (0, 10, 100, and 1000 nM) for 48 hours. Cells were fixed, permeabilized, and then incubated with anti-SRC1 (top panel), anti-SRC2 (middle panel), and anti-SRC3 (bottom panel) antibodies, followed by incubation with CY3-conjugated (red) secondary antibodies as appropriate. Cellular nuclei were monitored by DAPI (blue). Pictures were captured at ϫ200 magnification. D, HuLM cells were treated with increasing doses of 1,25(OH) 2 D3 (0, 10, 100, and 1000 nM) for 48 hours. Cytoplasmic (Cy) and nuclear (N) fractions were prepared as described in Figure 3 legend. Equal amounts of each fraction (15 g) were subjected to Western blot analyses using anti-SRC2, anti-SRC3, and anti-VDR antibodies. Western blot with anti-PARP and anti-RhoGDI antibodies were used to ensure extraction efficiency. NS, nonspecific. ciently reduces those nuclear receptors in a dose-dependent manner. Resultant Western blot data in Figure 3D evidenced well-defined bands in the cytoplasmic fractions as well; this could represent a cytoplasmic/cell membrane version of ER-␣ and VDR, or it could be nonspecific banding. We are unable to differentiate between these two possibilities at this point. VDR has also been shown to present in the cytoplasmic compartment of the cell system (46). Therefore, it is possible that the cytosolic band might represent the VDR that was not affected by 1,25(OH) 2 D3. We also observed that 1,25(OH) 2 D3 consistently induced VDR in HuLM cells. These findings suggest that the induction of VDR could be the central mechanism of 1,25(OH) 2 D3-mediated regulation of sex steroid hormone receptors in HuLM cells, although this approach cannot delineate direct interaction. Further analysis to identify such possible interaction using chromosomal immunoprecipitation (ChIP) and ChIP-seq techniques is in progress in our laboratory. SRCs are known to play important roles in ER-␣-mediated growth of UFs (47) . However, a single report has suggested that the levels of SRC mRNAs were up-regulated in 50% of UF cases (48) . Similar to this report, we detected up-regulation of SRC2 (50% of cases) and SRC3 (40% of cases) by Western blot analyses in human UFs (Figure 4) , suggesting that these coactivators may play important roles in UF pathogenesis. We further determined that 1,25(OH) 2 D3 significantly reduced SRC1, SRC2, and SRC3 in HuLM cells ( Figure 5, A and B) , demonstrating the potential of 1,25(OH) 2 D3 in the regulation of SRC family members. Our immunofluorescence and Western blot results demonstrated that SRCs were primarily localized in the nuclei of HuLM cells, whereas 1,25(OH) 2 D3 reduced nuclear expression in a dose-dependent manner ( Figure 5 , C and D). These results further demonstrate that 1,25(OH) 2 D3 has an important role in reducing the expression of nuclear SRC family members.
In a study conducted by Minghetti and Norman (49) , it was shown that 1,25(OH) 2 D3 functions through its own nuclear VDR, which forms a heterodimeric VDR-RXR-␣ complex that binds to the vitamin D response element (VDRE) on the promoter of target genes. Studies have also demonstrated a potential negative VDRE in the proximal promoter of the ER-␣ gene (44, 50) . We next performed a Co-IP assay to verify the physical interaction between VDR and RXR-␣ in HuLM cells. Our results in Figure 6A clearly demonstrate that VDR can physically interact with RXR-␣ in HuLM cells to form the VDR-RXR-␣ complex, which is further induced by 1,25(OH) 2 D3 due to induced levels of VDR. Thus, these results demonstrated that 1,25(OH) 2 D3 induced nuclear VDR and can form elevated levels of VDR-RXR-␣ complex, which may further bind to the VDRE on ER-␣ promoter and that ultimately suppress the gene expression of ER-␣.
In summary, we observed an association of higher levels of ER-␣, PR-A, or PR-B with reduced levels of VDR in human UFs. Estrogen suppressed the levels of VDR and induced the proliferation of HuLM cells, whereas 1,25(OH) 2 D3 significantly reduced the estrogen-induced proliferation of HuLM cells. Treatment of 1,25(OH) 2 D3 reduced the expression of nuclear ER-␣, PR-A, PR-B, and the nuclear SRC family members in HuLM cells. In contrast, 1,25(OH) 2 D3 induced its own VDR in a dose-and time-dependent manner in HuLM cells. Moreover, we showed that VDR can form a heterodimeric VDR-RXR-␣ complex in HuLM cells, whereas 1,25(OH) 2 D3 induced that complex due to the induction of VDR, suggesting that vitamin D-mediated reduction of steroid receptor gene expression requires VDR-RXR-␣ complex in HuLM cells. Future research study designs will seek to determine the detailed molecular mechanisms by which 1,25(OH) 2 D3 regulates ER-␣ gene expression in human UF cells.
